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Vitamin C, also known as ascorbic acid, abounds in nature and is highly labile.  It is 
a water-soluble vitamin that is lost in large amounts during food processing.  It is a 
vitamin whose prescribed requirement across cultures is not uniform. For example , 
the prescribed requirement of vitamin C in Great Britain is 30mg/day, while in the 
U.S.A.,  it is 60mg/day and 100mg/day in Japan. These variations are unusual and 
point to the need for further research to establish the acceptable RDAs for diverse 
populations. The RDA for vitamin C should be more than the amount needed to 
prevent the occurrence of disease. Vitamin C plays significant functions in the body 
that enhance its role in the health status of the human body. The biochemical 
functions of vitamin C include: stimulation of certain enzymes, collagen 
biosynthesis, hormonal activation, antioxidant, detoxification of histamine, 
phagocytic functions of leukocytes, formation of nitrosamine, and proline 
hydroxylation amongst others. These functions are related to the health effects of 
vitamin C status in an individual. In human health, vitamin C has been associated 
with reduction of incidence of cancer, blood pressure, immunity, and drug 
metabolism and urinary hydroxyproline excretion, tissue regeneration.  This 
vitamin is needed for the proper metabolism of drugs in the body through adequate 
hepatic mixed function oxidase system.  Epidemiological data have revealed the 
preventive and curative role of vitamin C on certain disease conditions in the body 
though controversies still persist. Vitamin C is effective in protecting against 
oxidative damage in tissues and also suppresses formation of carcinogens like 
nitrosamines.  There is an inverse relationship with blood pressure and both plasma 
vitamin C and Vitamin C.  Vitamin C has a lowering effect on blood pressure, 
especially on systolic pressure more than a diastolic pressure.  Low levels of plasma 
vitamin C are associated with stroke and with an increased risk of all cause 
mortality.  Increased consumption of ascorbic acid raises serum ascorbic levels and 
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La vitamine C, appelée également acide ascorbique, abonde en nature et elle est 
fortement labile.  C’est une vitamine soluble dans l’eau qui est perdue en grandes 
quantités pendant le traitement des produits alimentaires.  Il s’agit d’une vitamine 
dont la  prise prescrite dans les cultures n’est pas uniforme. Par exemple, la prise  
de la vitamine C prescrite en Grande-Bretagne est de 30mg/jour, tandis qu’aux 
Etats-Unis elle est de 60mg/jour et de 100mg/jour au Japon. Ces variations sont 
inhabituelles et elles indiquent la nécessité d’une recherche plus approfondie en vue 
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d’établir les AQR (Apports Quotidiennement Recommandés) acceptables pour 
diverses populations. Les AQR en  vitamine C devraient être supérieurs à la 
quantité requise pour prévenir l’apparition de maladies. La vitamine C joue dans le 
corps des  fonctions considérables qui augmentent son rôle dans l’état de santé du 
corps humain. Les fonctions biochimiques de la vitamine C sont notamment la 
stimulation de certains enzymes,  la biosynthèse des collagènes, l’activation des 
hormones, des antioxydants, la détoxification de l’histamine, des fonctions des 
phagocytes, des leucocytes, la formation de la nitrosamine, et l’hydroxylation 
proline, entre autres. Ces fonctions ont trait aux effets sanitaires de la teneur en 
vitamine C dans un individu. En matière de santé humaine, la vitamine C a été 
associée à la réduction de l’incidence du cancer et de la tension artérielle, à 
l’immunité,  au métabolisme des médicaments et à l’excrétion  hydroxyproline 
urinaire, ainsi qu’à la régénération des tissus.  Cette vitamine est nécessaire pour un 
bon métabolisme des médicaments dans le corps  par un système d’oxydase de 
fonctions mixtes hépatiques adéquates.  Des données épidémiologiques ont révélé le 
rôle  préventif et curatif de la vitamine C sur certaines conditions de maladies dans 
le corps bien que des  controverses persistent encore. La vitamine C est efficace dans 
la protection contre  des lésions oxydatives dans les tissus; elle supprime également  
la formation de cancérigènes tels que  les nitrosamines.  Il existe un rapport inverse 
entre la tension artérielle et la vitamine C du plasma et la vitamine C.  La vitamine 
C a un effet de réduction  sur la tension artérielle, plus particulièrement sur la 
pression systolique que sur la pression  diastolique.  Les niveaux peu élevés de la 
vitamine C du plasma sont associés à la congestion cérébrale et à un risque élevé de 
toutes les causes de la mortalité.  Une  consommation élevée d’acide ascorbique 












Ascorbic acid, commonly known as vitamin C plays significant functions in the human 
body, though its function at the cellular level is not very clear.  Vitamin C is needed for 
collagen synthesis, the protein that serves so many connective functions in the body.  
Among the body’s collagen-containing materials and structures are the framework of 
bone, gums and binding materials in skin muscle or scar tissue.  Production of certain 
hormones and of neurotransmitters and the metabolism of some amino acids and vitamins 
require vitamin C.  This vitamin also helps the liver in the detoxification of toxic 
substances in the system, and the blood in fighting infections.  Ascorbic acid is important 
in the proper function of the immune system.  As an antioxidant, it reacts with 
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compounds like histamines and peroxides to reduce inflammatory symptoms.  Its 
antioxidant property is associated with the reduction of cancer incidences [1, 2]. 
 
The requirement for vitamin C for adults does not seem to be uniform across cultures.  
This may be a pointer to the need for cultural-specific requirements for the nutrient.  It 
has now been appreciated that ascorbic acid functions in cellular reactions and processes.  
Epidemiological data now point to reduction of colds with increased consumption of 
foods rich in vitamin C [3].  People are tempted to over-consume vitamin C because of its 
health benefits.  Miniscule increases in blood vitamin C levels decrease the risk of death 
from all conditions [4].  This paper presents a review of epidemiological data on the role 
of ascorbic acid in certain human health conditions. Though there are many functions of 
vitamin C, its role in health is discussed in relation to cancer, blood pressure, immunity, 
drug metabolism and urinary hydroxyproline excretion. 
 
Vitamin C and Cancer 
Cancer is a global public health problem with increased mortality levels.  Though there 
are many types of cancers, the review presents a general picture of the role of ascorbic 
acid in cancer.  Vitamin C is effective in protecting against oxidative damage in tissues, 
and also suppresses formation of carcinogens like nitrosamines [4]. The WHO estimated 
an increase of over 10 million new cases of cancer.  Despite progress against some rare 
forms of cancer, the overall death rate has increased [5].  Though Vitamin C is cytotoxic 
to tumor cells but non-toxic to normal cells, conventional medicine favors more powerful 
and toxic chemotherapeutic agents.  Many studies have shown that vitamin C intake is 
inversely related to cancer, with protective effects shown for cancer of the lung, breast, 
pancreas, stomach, cervix, rectum and oral cavity [6].  The authors found that the 
oxidation of guanine, a purine in DNA was significantly reduced after vitamin C 
supplementation, but the oxidation of adenine also a purine was significantly elevated. 
The reduced level in the oxidation of guanine suggests that vitamin C acts as an 
antioxidant [5].  Extensive in vitro and in vivo vitamin C tests to determine its ability to 
prevent the adverse effects of, decrease the resistance to and increase the effects of 
chemotherapeutic have been conducted [7].  Combination of vitamin C and vitamin K 
given prior to chemotherapy increased survival and the effects of several 
chemotherapeutic agents in a murine ascitic living tumor model [8].  Vitamin C has also 
been shown to be safe to be used concurrently with radiation [9].  Administration of 
Vitamin A, β-carotene, E and C can reduce the incidence, and delay the progression of 
various cancers such as skin, those of the colon, stomach, esophagus, mammary glands 
and bladder  [1, 4, 10, 11].  Epidemiological studies have revealed an inverse relationship 
between the intake of vitamins A, β-carotene, C and E, and the incidence of different 
cancers in humans.  There is a decrease in cancer incidence and risk, in population with 
high content of these vitamins in the plasma.  Carcinogenesis is related to cell 
differentiation, progression and metabolism, and co                               
llagen synthesis.   
 
The basic mechanism for carcinogenesis is cell differentiation, because cancer develops 
when there is loss of cell differentiation.  Vitamins A, β-carotene, E and C have a 
profound influence on cell growth and differentiation.  Vitamin C is a strong antioxidant 
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that acts synergistically with Vitamin E as scavengers for free radicals in the body 
system, which are carcinogenic. Ascorbic acid, as sodium ascorbate exerts marked 
cytotoxic effects on several mammalian cells in culture.  These effects are dose 
dependent.  For example, Lupulescus [2] reported that vitamin C (upto 200 ug/ml) did not 
cause any morphological changes in mouse melanoma, mouse neuroblastoma, rat glioma 
and mouse fibroblasts in culture.  At high concentrations (500-1000 ug/ml), vitamin C 
was lethal for neuroblastoma cells.  Cytotoxic effects are also cell dependent, being 
stronger in human melanoma as compared to mouse melanoma cells.  It has been 
suggested that vitamin C induced cytotoxicity is mediated primarily by hydrogen 
peroxide formation at cell surface, or thin cells.  Cytotoxic activity can also be mediated 
by presence of cupric ions (Cu2+) in malignant melanoma cells that react with vitamin C 
and generate free radicals in solution.  Vitamin C also reverses the chemically 
transformed cells to thin normal phenotype. 
 
Ultra structure and cell surface studies of cancer cells following vitamin C administration 
revealed observed cytolysis, cell membrane disruption, mitochondrial alterations, nuclear 
and nucleolar reduction, and increased phagolysosome formation in cancer cells 
following vitamin C administration [10].  Cell surface changes such as cytolysis, 
increased collagen synthesis, and cell membrane disorganization were predominant, and 
increased apoptotic and phagocytic activity were also seen.  Quantitative estimation of 
cell organelles revealed that vitamin C affects the intracellular organelle distribution, 
playing an important role in cyto-differentiation of cell cancer [1, 10].  Hence, vitamins 
A, E and C markedly affect the cancer cells differentiation by exerting direct cytotoxic 
effects, modifying membrane biogenesis, light and gap junction formation, Golgi’s 
complex, autophagic and apoptotic activity, cell surface changes and sometimes reversing 
transformed cells to their normal cell type.  This reversal is necessary in the reduction of 
possible cancer incidences. 
 
Changes of DNA, RNA and protein synthesis have been associated with cell 
differentiation and proliferation. The mechanism of action, however, is not fully 
understood.  It has been suggested that most of the metabolic effects are mediated by 
transcription and translation processes at the genome level.  Further, vitamins A, E and C 
modulate DNA synthesis and gene expression in a similar manner to that of steroid 
hormones. These vitamins may affect chemical mutagenicity and cellular status [2].   By 
affecting DNA, RNA and proteins at specific sites that are targets of electrophiles, the 
vitamins can control cell replication rate, leading to an altered cell rearranged codons and 
translocation of specific genes, or oncogenes.  The vitamins A, E and C affect differently 
DNA, RNA and protein synthesis in cancer cells.  Administration of vitamin C decreases 
DNA synthesis in the nuclei, RNA synthesis in the nucleoli, and proteins in cytoplasm of 
cancer cells.  This inhibition of DNA, RNA and protein synthesis is accompanied by 




Vitamin C plays an important role in collagen synthesis. Collagen is an extracellular 
protein synthesized intracellularly as tropocollagen by the fibroblasts, and contains amino 
African Journal of Food Agriculture and Nutritional Development (AJFAND): Volume 5 No 1 2005 
 
 5
acids prolines, glycine and lysine.  The major reaction in collagen synthesis is 
hydroxylation of proline to 4-hydroxyproline.  This provides proper structural 
configuration and stability of collagen.  The enzyme 4-hydroxylase, which is a tetramer, 
catalyzes hydroxylation of proline and its genes are differently located in human 
chromosomes.  In some experiments ascorbic acid and its analogues specifically 
enhanced the collagen synthesis almost four-fold in cultured human skin fibroblasts, by 
increasing the incorporation of (3H-) proline into colagenase sensitive proteins.  L-
ascorbate was found to be the most active compound, [2].  It is also possible that ascorbic 
acid can stimulate collagen synthesis by other mechanisms, independent of 
hydroxylation.  Ascorbic acid induces lipid peroxidation and reactive aldehydes, a step 
required for collagen expression, collagen m-RNA levels, and collagen production in 
cultured human fibroblasts.   Collagen gene expression is probably influenced by lipid 
perodixation, or through acetaldehyde formation, which consequently increases collagen 
gene transcription in cultured human fibroblasts.  The mechanism by which vitamin C 
stimulates collagen gene expression is not very clear.  Ascorbic acid can, therefore, 
stimulate collagen synthesis independent of proline hydroxylation by inducing lipid 
peroxidation.  Ascorbic acid is thus the major vitamin regulating collagen synthesis, and 
provides stability to the procollagen single helix [1, 2]  
 
Blood Pressure 
Elevated blood pressure is a powerful determination of cerebro-vascular and coronary 
disease.  Great efforts have been made towards the detection and treatment of 
hypertension since the 1960s.  Some of the observed decrease in cardiovascular disease 
over the period has been attributed to better control of blood pressure among diagnosed 
hypertensives.  The importance of nutrition in control of blood pressure is well 
documented.  Obesity, dietary sodium and alcohol are associated with lower or higher 
blood pressure. Higher intake of polyunsaturated fatty acids and magnesium have also 
been linked with lower blood pressure [12]. 
 
Inverse associations with blood pressure and both plasma vitamin C and vitamin C have 
been reported.  A study of the relationship between fasting vitamin C and cerebrovascular 
disease risk factors revealed reduction in hypertension in men.  Men with serum vitamin 
C of 0.5 mg/dl had a mean systolic pressure of 122 mmHg compared with a mean of 113 
mmHg for men with serum vitamin C of 0.9 mg/dl, a relative difference of -7%.  The 
same men had a similar difference in diastolic pressure of 78 mmHg vs. 73 mmHg – 6% 
relative difference.  Prevalence of hypertension was 7.5% in the low serum vitamin C 
group versus 1.0% among those with high levels of vitamin C [13].  An investigation to 
identify the association between BP plasma antioxidant vitamin revealed a significant 
trend for both systolic and diastolic pressure over qualities of plasma vitamin C with a –
5% difference in systolic pressure and a –4% difference in diastolic BP between highest 
and lowest quintiles of plasma vitamin C [14].   
 
Similar significant negative trends between plasma vitamin C and both systolic and 
diastolic BP were observed in Chinese-American males and females aged 60-96 years 
who were not taking anti-hypertensive medication.  The difference between mean systolic 
and diastolic BP levels in the highest and lowest quartiles were –21 mmHg (-14%) and –
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8 mmHg (-9%), respectively [15].   Vitamin C appears to have a lowering effect on 
systolic pressure, more than it has on diastolic pressure. Other negative correlation 
between dietary vitamin C intake and both systolic and diastolic BP [16] and negative 
association between BP, and vitamin C intake and use of vitamin C supplements in 
Honolulu Heart Study [17] have also been reported.  Diastolic pressure was not 
associated with vitamin intake.  Individuals consuming vitamin C in adequate quantities 
are likely to have lower BP.  It is a cheaper form of supplementation for developing 
communities.   
 
In a randomized placebo-controlled, cross-over trial on a mixed sample of 12 borderline 
hypertensives and 8 normotensives, there was reported a 4.4% drop in systolic BP 
between the placebo treatment and vitamin C treatment after four weeks of 
supplementation with 1 gram of vitamin C [18].  Vitamin C supplementation did not 
influence diastolic pressure.  A cross-sectional study of the relationship of vitamin C 
intake and blood pressure in the elderly revealed relative differences in systolic and 
diastolic BP between subjects consuming 240 mg/day compared to those consuming 60 
mg/day were –6.9% and –6.6%, respectively.  The prevalence of elevated BP (systolic 
160 mmHg or diastolic 100 mmHg) was approximately 50% lower across this range 
vitamin C intake (60, 60-119, 120-179, 180-239 240mg/day) [19].  Vitamin C thus 
appears to have a lowering effect on blood pressure of the elderly. 
 
A prospective population-based cohort study of 2419 randomly selected middle aged men 
(42-60yrs) with no history of stroke was conducted to examine whether plasma vitamin C 
modifies the association between overweight and hypertension and stroke [20].  Men who 
had the lowest levels of plasma vitamin C were at a higher risk of developing any stroke 
compared to men who had the highest levels of plasma vitamin C.  Hypertensive men 
who had the lowest vitamin C levels were at an increased risk for any stroke and so were 
overweight men with low plasma vitamin C.  Low plasma vitamin C was associated with 
increased stroke risk. 
 
An increase in the intake of vitamin C during the dietary fat reduction period could have 
accounted for a part of the blood pressure reduction [14, 15].  Decreased plasma ascorbic 
acid levels were associated with reduced plasma concentrations of 6-ketoprostaglandin-F, 
the metabolite prostacylin.  Thus dietary antioxidants enhance production of prostacyclin 
by scavenging free radicals and peroxides, which inhibit prostacylin synthetase at 
concentrations above a certain threshold. Thus vitamin C and blood pressure appear to be 
related, in that adequate dietary vitamin C could exert a reducing effect on blood 
pressure, and especially if dietary fat intake is reduced. 
 
Vitamin C and Immunity 
In stressful situations adrenal glands react by releasing hormones that trigger the “fight or 
flight” reaction.  It has been indicated that 200mg of vitamin C a day may reduce the 
levels of stress hormones.  Stress suppresses the immune system.  Mega doses of vitamin 
C increase the levels of antibody that fights against germs and viruses in both stressed 
and unstressed rats, with greater antibody increase in the unstressed rats [21].  Stressed 
animals may need larger vitamin C doses for proper function of the immune system. 




Healing of wounds is characterized by synthesis of connective tissue, the major 
component of which is collagen.  Ascorbic acid has important biological and metabolic 
functions, particularly with respect to its role in the biosynthesis of connective tissue 
[22].  Ascorbic acid is required for the hydroxylation of prolyl and lysl residues during 
collagen biosynthesis [23, 24, 25].  The supplementation of ascorbic acid is necessary to 
heal wounds since ascorbic acid may be oxidized during collagen synthesis [26]. 
 
Considerable evidence is available to document an interaction between vitamin C and 
phagocytic cells.  Cells collected from blood, peritoneal or alveolan fluids, normally 
contain high (1-2 ug/mg protein) concentrations of vitamin C and in other in vitro 
conditions leukocytes can take up vitamin C.  Neutrophils have been studied in vitro 
under conditions of vitamin C deprivation and excess [27, 28, 29].  Neutrophils from 
guinea pigs produce H2O2 and kill staphylococci as well as control cells. Ascorbate and 
dehydroascorbate are both utilized during phagocytic process [29].  Neutropholis may 
avoid poisoning themselves by absorbing extra ascorbic acid, which can neutralize 
antioxidants. 
 
However, the glycolytic activity did not increase maximally in neutrophils from ascorbic 
guinea pigs and the stimulation of NADPH oxidase activity was depressed [27, 28].  The 
addition of ascorbate to cultures of normal macrophages increases the cellular 
concentrations of cyclic GMP (cGMP) as well as HMP shunt [30].  Although the in vitro 
addition of ascorbate in very large amounts may inhibit H2O2 – myeloperoxidase-halide 
activity, it does not alter bacteriocidal capacity of cells.  An increase in the in vitro 
concentrations of ascorbate increased phagocytic activity of cultural mouse peritoneal 
macrophages [31].  The addition of vitamin C cultures of neutrophil or macrophages 
increased their motility and chemotactic activity.  
 
A defect in which a failure of the umbilicus to separate in newborn infants led to severe 
local and disseminated bacterial infection [32].  Two surviving had decreased neutrophil 
mobility that improved with the oral administration of ascorbic acid in doses of 200-800 
mg/day, as well as in vitro addition of vitamin C to defective neutrophils.  The ability of 
human neutrophils to kill Candida albicans occurs best at physiological in vitro 
concentrations of L-ascorbic acid.  The locomotor functions, for example. random motion 
and chemotactic migration of neutrophils and macrophages are impaired in the absence of 
vitamin C. 
Vitamin C may influence the ability of certain cell lines to produce interferon when 
approximately stimulated.  The addition of ascorbic acid to cultures of human embryo 
skin or to fibroblasts led to induction of interferon.  Vitamin C appears to be required by 
thymus for the maintenance of certain cells, possibly certain reticular cells that are 
concerned with the production of thymic humoral factor.  Thymic content of 
dehydroascorbate decreased in direct proportion to vitamin C.  The hormone activity of 
thymic extracts correlated with thymic ascorbate and inversely with dehydroascorbate 
[33].  A prospective controlled study of students (18-32 years) in a technical training 
facility was conducted to assess the effect megadose vitamin C in preventing and 
relieving cold and flu symptoms [3].  The numbers of reports of cold and flu symptoms 
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were recorded for both the test and control groups.  Students in the test group were 
treated with hourly doses of 100 mg of vitamin C for the first six hours and then three 
times thereafter while those in the control group were treated with pain relievers and 
decongestants.  The reported cold and flu symptoms in the test group decreased by 85% 
more than the control group after the administration of the megadose vitamin C. 
 
Drug Metabolism 
Vitamin C functions as a cofactor in hydroxylation reactions of collagen and 
catecholamine synthesis.  It appears to be involved in a wide range of processes including 
macrophage function, carnitine synthesis and drug metabolism.  Studies in guinea pigs 
have demonstrated that vitamin C deficiency alters the concentration and activity of 
components of the hepatic mixed function oxidase system and impairs the metabolism of 
a wide range of drugs.  Much less is known about the effects of different vitamin C 
intakes on drug metabolism in humans.  The few studies that have been conducted have 
not always been properly controlled and have yielded conflicting results  [34, 35].  
Discrepancies between studies may be due to the different drugs used and the extent of 
depletion achieved.  This calls for the need to conduct research of vitamin C on particular 
drugs which could be financially and resourcefully expensive, though may clarify the role 
of vitamin C in drug metabolism. 
 
Nutritional deficiencies have been shown to affect the kinetics of many drugs directly by 
altering their metabolism.  Specifically vitamin C has been shown to influence the 
oxidative metabolism of a variety of drugs, including some oxidative demethylation 
processes in guinea pigs.  A study of  the influence of vitamin C on pharmacokinetics of 
caffeine in healthy elderly men  reported that short-term alterations in vitamin C intake 
do not affect caffeine metabolism in elderly men [36].   In another study of the effects of 
vitamin C on the elimination of antipyrine in 14 healthy adults (24–25 years), added 
vitamin C had no effect on the pharmacokinetics of antipyrine [37].  In contrast, there 
was an increased metabolic clearance of antipyrine after administration of vitamin C to 
non deficient young subjects and vitamin C deficiency elderly subjects [35, 37].  
Assessment of the influence of subclinical ascorbic acid deficiency on drug metabolism 
revealed that pronounced ascorbic acid deficiency of relatively short duration does not 
alter antipyrine metabolism in man [38].  In contrast, vitamin C has repeatedly been 
shown to depress drug-metabolizing enzyme activity in guinea pigs [39, 40].  There is 
need to understand these effects in human populations. 
 
Hepatic mixed function oxidase activity was measured in Gambian men during a period 
of low seasonal vitamin D intake after supplementation.  Demythylation of 
methodyphelacetamide (methacetin) was followed using breath test, in which exhalation 
of 13C-enriched CO2  was measured following an oral dose of 13C-methacetin.  Vitamin 
supplementation, sufficient to increase plasma levels significantly, did not influence 
methacetin metabolism.  However, methacetin metabolism in unsupplemented men 
appeared normal in majority of cases.  Hepatic tissue may not have been sufficiently 
depleted of vitamin C to impair the activity of the mixed function oxidase system.  There 
is need to understand the effect of vitamin C on the mixed function oxidase system in 
hepatic tissues that are sufficiently depleted of the vitamin [41]. 




Urinary Hydroxyproline Excretion 
Many clinical problems associated with ascorbic acid deficiency such as abnormalities of 
skeleton seen in infantile scurvy, lesions of gingiva, as well as impairment of wound 
healing of bony structures are related to collagen metabolism.  Urinary excretion of 
hydroxyproline is considered to be a useful indicator of changes in metabolism of 
collagen because with the exception of the small amounts of hydroxyproline in elastin 
and component Uq (a hydroxy-proline rich in protein) in plasma no other protein contains 
a significant amount of this amino acid [42].  Collagen is much more abundant than these 
other hydroxyproline-containing  proteins and comprises about one-third of the total body 
protein, which justifies the use of hydroxyproline in following changes in collagen 
turnover.  There was reported an increase in urinary hydroxyproline by an average of 
16% and 30% after first and second depletion periods, and decreased to baseline after 
supplementation with normal or high doses of ascorbic acid [43].  They concluded that 
urinary hydroxyproline excretion increases during human vitamin C deficiency but that 
this effect is not strong to provide a reliable marker of vitamin C deficiency. 
 
Conclusion  
Ascorbic acid is needed for various functions in the body, though its function at the 
cellular level remains unclear.  Ascorbic acid is needed for collagen synthesis, a 
production of certain hormones and of neurotransmitters, metabolism of some amino 
acids and vitamins, detoxification of toxic substances in the body, and proper function of 
the immune system.  The vitamin C requirements are not uniform across cultures, and 
hence need for further research in setting appropriate RDAs for vitamin C.   
 
Epidemiological data is increasing on the effect of vitamin C in cancer, blood pressure, 
immunity drug metabolism and urinary hydroxyproline excretion.  Vitamin C is effective 
in protecting against oxidative damage in tissues and also suppresses formation of 
carcinogens like nitrosamines.  High levels of serum ascorbic acid reduce blood pressure, 
especially systolic blood pressure.  Low plasma vitamin C is associated with increased 
risk of stroke.  Mega doses of vitamin C increases the levels of an antibody that fights 
against infections in both stressed and unstressed rats, with greater increase in the 
unstressed rats.  Larger doses of vitamin C may be necessary for proper function of the 
immune system.  Mega doses of vitamin C decreases the symptoms of cold and flu in 
humans.  Though reports show that vitamin C influences the oxidative metabolism of a 
variety of drugs in guinea pigs, there is need to understand the effects in human 
populations.  The role of vitamin C in the prevention and control of disease states is 
encouraging, since it is a cheaper way of enhancing vitamin C status through diets, 
instead of use of supplements that may be quite expensive. Vitamin C abounds in nature 
and thus in diets.  However, it is highly labile and is destroyed through the methods of 
processing employed in food handling from harvesting through conservation and 
preparation stages.  Principles of nutrient preservation through all these stages should be 
carefully applied. 
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